Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells

Journal of Biomolecular Screening

Volumn 9, Issue 8, 2004, Pages 704-711

  Yauch, Robert L ^a,b   Kadel III, Edward E ^a   Nicholas, Cory ^a   Tetangco, Selwyna ^a   Clary, Douglas O ^a  

^a SUGEN INC   (United States)

^b GENENTECH INC   (United States)

Author keywords

Adenovirus; Functional genomics; TNF ; VEGF

Indexed keywords

CYTOKINE; GENE PRODUCT; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADENOVIRUS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG IDENTIFICATION; DRUG SCREENING; ENDOTHELIUM CELL; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE IDENTIFICATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN GENOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VIRUS RECOMBINANT;

ADENOVIRIDAE; BIOLOGICAL ASSAY; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENE LIBRARY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENOMICS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 16844379235     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057104268698     Document Type: Article

References (24)

1. Giese K, Kaufmann J, Pronk GJ, Klippel A: Unravelling novel intracellular pathways in cell-based assays. Drug Discov Today 2002;7:179-186.
2. Madge LA, Pober JS: TNF signaling in vascular endothelial cells. Exp Mol Pathol 2001;70:317-325.
3. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
4. Manley PW, Martiny-Baron G, Schlaeppi JM, Wood JM: Therapies directed at vascular endothelial growth factor. Expert Opin Investig Drugs 2002;11:1715-1736.
5. Taylor PC: Anti-tumor necrosis factor therapies. Curr Opin Rheumatol 2001;13:164-169.
6. Ma L, Bluyssen HA, De Raeymaeker M, et al: Rapid determination of adenoviral vector titers by quantitative real-time PCR. J Virol Methods 2001;93:181-188.
7. Clauss M, Gerlach M, Gerlach H, et al: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
8. Pober JS, Gimbrone MA Jr, Lapierre LA, et al: Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986;137:1893-1896.
9. Mechtcheriakova D, Wlachos A, Holzmuller H, Binder BR, Hofer E: Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. Blood 1999;93:3811-3823.
10. Mechtcheriakova D, Schabbauer G, Lucerna M, et al: Specificity, diversity, and convergence in VEGF and TNF-α signaling events leading to tissue factor upregulation via EGR-1 in endothelial cells. FASEB J 2001;15:230-242.
11. Voraberger G, Schafer R, Stratowa C: Cloning of the human gene for intercellular adhesion molecule 1 analysis of its 5′-regulatory region: induction by cytokines and phorbol ester. J Immunol 1991;147:2777-2786.
12. Zachary I, Gliki G: Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49:568-581.
13. Blum S, Issbruker K, Willuweit A, et al: An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem 2001;276:33428-33434.
14. Michiels F, van Es H, van Rompaey L, et al: Arrayed adenoviral expression libraries for functional screening. Nat Biotechnol 2002;20:1154-1157.
15. Mercurio F, Zhu H, Murray BW, et al: IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997;278:860-866.
16. Mackman N: Regulation of the tissue factor gene. FASEB J 1995;9:883-889.
17. Kim I, Oh JL, Ryu YS, et al: Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J 2001;16:126-128.
18. Gonzalez JE, Negulescu PA: Intracellular detection assays for high-throughput screening. Curr Opin Biotechnol 1998;9:624-631.
19. Strawn LM, McMahon G, App H, et al: Flk-1 as a target for tumor growth inhibition. Cancer Res 1996;56:3540-3545.
20. Wood JM, Bold G, Buchdunger E, et al: PTK787/ZK222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 2000;60:2178-2189.
21. Leung KH: Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes. Biochem Biophys Res Commun 1999;260:734-739.
22. Zerwes HG, Peter JC, Link M, Gubler H, Scheel G: A multiparameter screening assay to assess the cytokine-induced expression of endothelial cell adhesion molecules. Anal Biochem 2002;304:166-173.
23. Davis GF, Downs TR, Farmer JA, et al: Comparison of high throughput screening technologies for luminescence cell-based reporter screens. J Biomol Screen 2002;7:67-77.
24. Huang WC, Chen J, Chen CC: c-Src-dependent tyrosine phosphorylation of IKKβ is involved in tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression. J Biol Chem 2003;278:9944-9952.